DK146213C - Fremgangsmaade til fremstilling af smaalegemer med kontrolleret afgivelse af en aktiv komponent - Google Patents

Fremgangsmaade til fremstilling af smaalegemer med kontrolleret afgivelse af en aktiv komponent

Info

Publication number
DK146213C
DK146213C DK513476A DK513476A DK146213C DK 146213 C DK146213 C DK 146213C DK 513476 A DK513476 A DK 513476A DK 513476 A DK513476 A DK 513476A DK 146213 C DK146213 C DK 146213C
Authority
DK
Denmark
Prior art keywords
procedure
manufacture
active component
controlled release
small bodies
Prior art date
Application number
DK513476A
Other languages
Danish (da)
English (en)
Other versions
DK146213B (da
DK513476A (da
Inventor
Conny Boerje Bogentoft
Curt Henry Appelgren
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of DK513476A publication Critical patent/DK513476A/da
Publication of DK146213B publication Critical patent/DK146213B/da
Application granted granted Critical
Publication of DK146213C publication Critical patent/DK146213C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fertilizers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK513476A 1975-11-17 1976-11-15 Fremgangsmaade til fremstilling af smaalegemer med kontrolleret afgivelse af en aktiv komponent DK146213C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE7512883 1975-11-17
SE7512883A SE418247B (sv) 1975-11-17 1975-11-17 Sett att framstella kroppar med reglerad frigoring av en aktiv komponent

Publications (3)

Publication Number Publication Date
DK513476A DK513476A (da) 1977-05-18
DK146213B DK146213B (da) 1983-08-01
DK146213C true DK146213C (da) 1984-01-16

Family

ID=20326096

Family Applications (1)

Application Number Title Priority Date Filing Date
DK513476A DK146213C (da) 1975-11-17 1976-11-15 Fremgangsmaade til fremstilling af smaalegemer med kontrolleret afgivelse af en aktiv komponent

Country Status (24)

Country Link
US (2) US4289795A (US20030199744A1-20031023-C00003.png)
JP (1) JPS5919526B2 (US20030199744A1-20031023-C00003.png)
AT (1) AT354636B (US20030199744A1-20031023-C00003.png)
AU (1) AU508266B2 (US20030199744A1-20031023-C00003.png)
BE (1) BE848406A (US20030199744A1-20031023-C00003.png)
CA (1) CA1075031A (US20030199744A1-20031023-C00003.png)
CS (1) CS207374B2 (US20030199744A1-20031023-C00003.png)
DD (1) DD128170A5 (US20030199744A1-20031023-C00003.png)
DE (1) DE2651176A1 (US20030199744A1-20031023-C00003.png)
DK (1) DK146213C (US20030199744A1-20031023-C00003.png)
FI (1) FI62462C (US20030199744A1-20031023-C00003.png)
FR (1) FR2331375A1 (US20030199744A1-20031023-C00003.png)
GB (1) GB1560841A (US20030199744A1-20031023-C00003.png)
HK (1) HK14683A (US20030199744A1-20031023-C00003.png)
HU (1) HU173461B (US20030199744A1-20031023-C00003.png)
IE (1) IE44353B1 (US20030199744A1-20031023-C00003.png)
LU (1) LU76215A1 (US20030199744A1-20031023-C00003.png)
MY (1) MY8400019A (US20030199744A1-20031023-C00003.png)
NL (1) NL187259C (US20030199744A1-20031023-C00003.png)
NO (1) NO144763C (US20030199744A1-20031023-C00003.png)
NZ (1) NZ182621A (US20030199744A1-20031023-C00003.png)
SE (1) SE418247B (US20030199744A1-20031023-C00003.png)
SU (1) SU1326180A3 (US20030199744A1-20031023-C00003.png)
ZA (1) ZA766669B (US20030199744A1-20031023-C00003.png)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE426548B (sv) * 1978-12-05 1983-01-31 Haessle Ab Fast farmaceutisk beredning innehallande en terapeutiskt effektiv hjertglykosid och en polymer
FR2470600A2 (fr) * 1979-12-07 1981-06-12 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
SE7813246L (sv) 1978-12-22 1980-06-23 Haessle Ab Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
IE48715B1 (en) * 1978-12-22 1985-05-01 Elan Corp Plc New galencial forms for administration of medicaments by oral route,with programmed release and processes for preparing same
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
JPS5911563B2 (ja) * 1980-02-27 1984-03-16 日本原子力研究所 多層構造の徐放性複合体を製造する方法
ATE14379T1 (de) * 1981-04-27 1985-08-15 Haessle Ab Pharmazeutisches praeparat.
JPS5858146A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
EP0094123A3 (en) * 1982-05-06 1984-07-25 THE PROCTER & GAMBLE COMPANY Therapeutic granules
EP0094117A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
EP0094116A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
EP0111560A4 (en) * 1982-06-14 1987-02-03 Key Pharma ASPIRINE WITH CONTINUOUS LEVEL.
US4508702A (en) * 1982-06-14 1985-04-02 Key Pharmaceuticals, Inc. Sustained release aspirin
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
WO1984000295A1 (en) * 1982-07-09 1984-02-02 Key Pharma Sustained release quinidine dosage form
US4634587A (en) * 1982-07-09 1987-01-06 Key Pharmaceuticals, Inc. Sustained release quinidine dosage form
CA1223172A (en) * 1982-09-23 1987-06-23 Sidney Melamed Encapsulated solid microbiocidal article
US5283060A (en) * 1982-09-29 1994-02-01 Shieh Tsuong R Bacillus-containing pesticide granules
IL70071A (en) * 1982-11-01 1987-12-31 Merrell Dow Pharma Multilayered sustained release pharmaceutical tablets having non-uniform distribution of active ingredient
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
JPS59155309A (ja) * 1983-02-22 1984-09-04 Teijin Ltd 活性型ビタミンｄ↓３類組成物
DE3306250A1 (de) * 1983-02-23 1984-08-23 Basf Ag, 6700 Ludwigshafen Sphaerische einkristalle fuer pharmazeutische zwecke
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
GB2141023B (en) * 1983-06-06 1986-09-03 Robins Co Inc A H Delayed release formulations
US4555399A (en) * 1983-11-18 1985-11-26 Key Pharmaceuticals, Inc. Aspirin tablet
US4708867A (en) * 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DE3403329A1 (de) * 1984-02-01 1985-08-01 Horst Dr. 4019 Monheim Zerbe Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe
US4600645A (en) * 1985-01-31 1986-07-15 Warner-Lambert Company Process for treating dosage forms
US4693886A (en) * 1985-04-22 1987-09-15 Alza Corporation Osmotic device with inert core
SE458576B (sv) * 1985-06-20 1989-04-17 Lejus Medical Ab Foerfarande foer framstaellning av en guar-gum produkt
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
US4898733A (en) * 1985-11-04 1990-02-06 International Minerals & Chemical Corp. Layered, compression molded device for the sustained release of a beneficial agent
US4826688A (en) * 1985-11-13 1989-05-02 501 Elan Corporation PLC. Controlled absorption pharmaceutical formulation
US5019302A (en) * 1986-03-12 1991-05-28 Washington University Technology Associates, Inc. Method for granulation
US5100592A (en) * 1986-03-12 1992-03-31 Washington University Technology Associated, Inc. Method and apparatus for granulation and granulated product
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
EP0294493A4 (en) * 1986-12-25 1989-07-24 Teysan Pharmaceuticals Co Ltd SLOW DISSOLUTION GRANULE AND COMPOSITE GRANULE WITH PERSISTENT EFFECT PREPARED FROM THE FIRST GRANULE.
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
GB8702411D0 (en) * 1987-02-03 1987-03-11 Zyma Sa Swellable pellets
HU197519B (en) * 1987-06-22 1989-04-28 Biogal Gyogyszergyar Process for producing medicine form capable for penetrating through epidermis and suitable for intaking the agent through epidermis by kinetics of zero-grade
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
US5219575A (en) * 1987-06-26 1993-06-15 Duphar International Research B.V. Compositions with controlled zero-order delivery rate and method of preparing these compositions
EP0297650A1 (en) * 1987-06-26 1989-01-04 Duphar International Research B.V Compositions with controlled zero-order delivery rate and method of preparing these compositions
DE3721721C1 (de) * 1987-07-01 1988-06-09 Hoechst Ag Verfahren zur Umhuellung von Granulaten
IT1231410B (it) * 1987-09-22 1991-12-04 Cooperativa Farmaceutica Composizione farmaceutica antiinfiammatoria ad effetto prolungato per uso topico
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
US4971805A (en) * 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
US4925675A (en) * 1988-08-19 1990-05-15 Himedics, Inc. Erythromycin microencapsulated granules
US4925674A (en) * 1988-08-25 1990-05-15 Himedics, Inc. Amoxicillin microencapsulated granules
US4971796A (en) * 1988-10-05 1990-11-20 Sjogren Robert D Slow release pest control granule composition
DE3838094A1 (de) * 1988-11-10 1990-05-17 Nordmark Arzneimittel Gmbh Feste pharmazeutische retardform
US5055307A (en) * 1988-12-29 1991-10-08 Asahi Kagaku Kogyo Kabushiki Kaisha Slow release drug delivery granules and process for production thereof
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
DE3918801A1 (de) * 1989-06-06 1991-05-08 Schmidt Walter Praeparat zur geregelten wirkstoffabgabe und verfahren zu dessen herstellung
JP2813809B2 (ja) * 1989-06-19 1998-10-22 武田薬品工業株式会社 有核顆粒製剤およびその製造法
US4966770A (en) * 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
US5707652A (en) * 1990-12-04 1998-01-13 State Of Oregon Methods of treating circadian rhythm phase disorders
US6638963B1 (en) 1990-12-04 2003-10-28 Oregon Health And Science University Methods for treating circadian rhythm disorders
US5153002A (en) * 1991-03-04 1992-10-06 University Of Montreal Biocompatible gradient controlled release implant
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
GB2267219B (en) * 1992-05-28 1996-04-03 Elan Corp Plc Differential release tablet with multiple active agents
US5662935A (en) * 1992-12-23 1997-09-02 Saitec S.R.L. Process for preparing controlled release pharmaceutical forms and the forms thus obtained
IT1274879B (it) * 1994-08-03 1997-07-25 Saitec Srl Apparecchio e metodo per preparare forme farmaceutiche solide a rilascio controllato del principio attivo.
DE4446468A1 (de) * 1994-12-23 1996-06-27 Basf Ag Verfahren zur Herstellung von umhüllten Tabletten
US5762963A (en) * 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
GB9703673D0 (en) * 1997-02-21 1997-04-09 Bradford Particle Design Ltd Method and apparatus for the formation of particles
EP1949890A3 (en) 1999-06-04 2011-05-18 ALZA Corporation Implantable gel compositions and method of manufacture
PL351948A1 (en) * 1999-06-04 2003-07-14 Alza Corp Implantable gel compositions and method of making thereof
PT1276470E (pt) 2000-04-20 2007-08-13 Novartis Ag Composição de revestimento para dissimular o sabor
KR100402053B1 (ko) * 2000-09-28 2003-10-17 한국화학연구원 항생제의 서방성 임플란트 제제
GB0027357D0 (en) * 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
JP4551089B2 (ja) * 2001-10-29 2010-09-22 マサチューセッツ インスティテュート オブ テクノロジー 三次元印刷により製造されたゼロ次放出プロフィール投薬形態のような徐放投薬形態を製造するためのシステム
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
GB0216562D0 (en) 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
GB0228421D0 (en) * 2002-12-05 2003-01-08 Exosect Ltd Lipid carriers
DE10260919A1 (de) * 2002-12-20 2004-07-01 Röhm GmbH & Co. KG Verfahren zur Herstellung von überzogenen Arzneiformen und Nahrungsergänzungsmitteln mit Konzentrationsgradienten im Überzug
MXPA05011343A (es) 2003-05-08 2005-12-12 Nektar Therapeutics Uk Ltd Materiales particulados.
GB0310636D0 (en) * 2003-05-08 2003-06-11 Nektar Therapeutics Uk Ltd Particulate materials
CN100544596C (zh) * 2004-03-31 2009-09-30 Eid帕里(印度)有限公司 改进的印度楝种子提取物的颗粒制剂及其产生方法
US20050244465A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Drug delivery systems and methods for treatment of an eye
ES2325599T3 (es) * 2005-01-06 2009-09-09 Cima Labs Inc. Sistema de enmascaramiento del sabor para farmacos no plastificantes.
US9808030B2 (en) 2011-02-11 2017-11-07 Grain Processing Corporation Salt composition
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2928770A (en) * 1958-11-28 1960-03-15 Frank M Bardani Sustained action pill
BE623704A (US20030199744A1-20031023-C00003.png) * 1961-10-20
US3383283A (en) * 1964-01-24 1968-05-14 Merck & Co Inc Medicinal pellets coated with overlapping porous fatty acid leaflet layers
FR1545612A (fr) * 1967-06-15 1968-11-15 Dausse Lab Procédé de fabrication de comprimés
DE1617351A1 (US20030199744A1-20031023-C00003.png) * 1967-06-28 1972-01-05
DK123806B (da) * 1970-06-08 1972-08-07 Pharmacia As Fremgangsmåde til fremstilling af tabletter eller piller med langsom afgivelse af et aktivt stof.
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
BE792502A (fr) * 1971-12-09 1973-06-08 Upjohn Co Nouvelles formes pharmaceutiques et leur procede de preparation

Also Published As

Publication number Publication date
NL187259B (nl) 1991-03-01
US4341759A (en) 1982-07-27
MY8400019A (en) 1984-12-31
CA1075031A (en) 1980-04-08
DK146213B (da) 1983-08-01
HU173461B (hu) 1979-05-28
NL7612728A (nl) 1977-05-20
NZ182621A (en) 1978-12-18
FI62462B (fi) 1982-09-30
AT354636B (de) 1979-01-25
FR2331375A1 (fr) 1977-06-10
CS207374B2 (en) 1981-07-31
FI763257A (US20030199744A1-20031023-C00003.png) 1977-05-18
IE44353L (en) 1977-05-17
SE418247B (sv) 1981-05-18
AU508266B2 (en) 1980-03-13
IE44353B1 (en) 1981-11-04
BE848406A (fr) 1977-05-17
ATA850576A (de) 1979-06-15
DK513476A (da) 1977-05-18
NO763807L (US20030199744A1-20031023-C00003.png) 1977-05-20
NO144763C (no) 1981-11-04
SE7512883L (sv) 1977-05-18
DE2651176A1 (de) 1977-05-18
NL187259C (nl) 1991-08-01
US4289795A (en) 1981-09-15
AU1961776A (en) 1978-05-25
JPS5283921A (en) 1977-07-13
DE2651176C2 (US20030199744A1-20031023-C00003.png) 1987-06-11
JPS5919526B2 (ja) 1984-05-07
SU1326180A3 (ru) 1987-07-23
DD128170A5 (de) 1977-11-02
HK14683A (en) 1983-05-13
GB1560841A (en) 1980-02-13
LU76215A1 (US20030199744A1-20031023-C00003.png) 1977-06-06
ZA766669B (en) 1977-10-26
NO144763B (no) 1981-07-27
FI62462C (fi) 1983-01-10
FR2331375B1 (US20030199744A1-20031023-C00003.png) 1981-12-31

Similar Documents

Publication Publication Date Title
DK146213C (da) Fremgangsmaade til fremstilling af smaalegemer med kontrolleret afgivelse af en aktiv komponent
DK49676A (da) Fremgangsmade til fremstilling af hypolipidemiske midler
DK148907C (da) Analogifremgangsmaade til fremstilling af dihydrocyclosporin c
DK107876A (da) Fremgangsmade til fremstilling af thiocarbamider
DK535476A (da) Fremgangsmade til fremstilling af 7-methoxycephalosporiner
DK387876A (da) Fremgangsmade til fremstilling af oxazolidinoner
DK372976A (da) Fremgangsmade til fremstilling af siliciumhullegemer
DK148139C (da) Analogifremgangsmaade til fremstilling af 5-benzyl-2-oxazolidonderivater
DK150676A (da) Fremgangsmade til fremstilling af krystallinsk natrium-o-formyl-cefamandol
DK229976A (da) Fremgangsmade til fremstilling af fluordehydroxyl-derivater af organiske alkoholer
DK329476A (da) Fremgangsmade til forbedring af novolakbundne formlegemers mekaniske egenskaber
DK146629C (da) Analogifremgangsmaade til fremstilling af depotsteroidestere
DK122876A (da) Fremgangsmade til fremstilling af foderstoffer
DK34276A (da) Fremgangsmade til fremstilling af naphthylderivater
DK127976A (da) Fremgangsmade til fremstilling af thiazolinonderivater
DK399976A (da) Fremgangsmade til fremstilling af aralkylamider
DK415576A (da) Fremgangsmade til fremstilling af krystallinsk dipilocarpiniumpamoat
DK142990C (da) Fremgangsmaade til fremstilling af antibakterielt virksomme aldehydderivater af clavulansyre
DK141584C (da) Fremgangsmaade til fremstilling af slagseje vinylaromat-podecopolymere
DK526676A (da) Fremgangsmade til fremstilling af 4-chlor-2-butynyl-m-chlorcarbanilat
DK424676A (da) Fremgangsmade til fremstilling af 2-alkylindan
DK480676A (da) Fremgangsmade til fremstilling af s-alkylphosphordihalogeniddithioater
DK177176A (da) Fremgangsmade til fremstilling af cyclopentanderivater
DK46476A (da) Fremgangsmade til fremstilling af 5-nitrothiazolylimidazolidiner
DK196076A (da) Fremgangsmade til fremstilling af oxazol-urinstofderivater

Legal Events

Date Code Title Description
PBP Patent lapsed